Literature DB >> 23426963

Low-grade, metastasizing splenic littoral cell angiosarcoma presenting with hepatic cirrhosis and splenic artery aneurysm.

Brandon T Larsen1, Maria C Bishop, Glenn C Hunter, Stephen W Renner.   

Abstract

The behavior of littoral cell neoplasms ranges from benign (littoral cell angioma, LCA) to highly malignant (angiosarcoma). Two unusual cases of low-grade metastatic littoral cell angiosarcoma (LCAS) have been reported with late recurrence and bulky metastases. We present the third case of this rare neoplasm in a 38-year-old man with cirrhosis and a large splenic artery aneurysm, without extrasplenic masses. The spleen showed nodules resembling LCA, immunoreactive for CD31, factor VIII, CD68, and CD163 but not CD8 or CD34. Also present were solid areas of immunophenotypically identical bland spindle cells, although lighter CD31 immunostaining distinguished them from LCA-like angiomatous channels. Similar cells diffusely infiltrated the cirrhotic liver. After splenectomy, pancytopenia resolved, and he is asymptomatic 19 months later. Low-grade LCAS is a previously unreported cause of cirrhosis and may metastasize without forming masses. In cases of LCA, CD31 immunohistochemistry may facilitate detection of LCAS and indicate metastatic potential.

Entities:  

Keywords:  cirrhosis; littoral cell angioma; littoral cell angiosarcoma; splenic artery aneurysm; splenic vascular neoplasm

Mesh:

Substances:

Year:  2013        PMID: 23426963     DOI: 10.1177/1066896913476737

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Littoral cell angioma: gastrointestinal associations.

Authors:  John J Sarandria; Maria Escano; Farin Kamangar; Saleem O Farooqui; Elizabeth Montgomery; Steven C Cunningham
Journal:  Gastrointest Cancer Res       Date:  2014-03

2.  Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report.

Authors:  Kotoe Takayoshi; Goro Doi; Nobuhiro Tsuruta; Tomoyasu Yoshihiro; Kenta Nio; Kenji Tsuchihashi; Hiroshi Ariyama; Jun Odawara; Shinji Shimoda; Kenichi Kohashi; Yoshinao Oda; Shinji Itoh; Norifumi Harimoto; Yoshihiko Maehara; Hitoshi Kusaba; Koichi Akashi; Eishi Baba
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.